Podcasts about radiological society

Una dieta ricca di cibi ultra-processati è associata a maggiori quantità di grasso immagazzinato all'interno dei muscoli, indipendentemente dalla quantità di calorie consumate o dal livello di attività fisica, secondo uno studio presentato al meeting annuale della Radiological Society of North America (RSNA). La ricerca ha anche confermato che il declino quantitativo e funzionale dei muscoli della coscia è potenzialmente associato all'insorgenza e alla progressione dell'osteoartrite del ginocchio. Il cardine della prevenzione è legato ai fattori modificabili dello stile di vita, in particolare la prevenzione dell'obesità tramite una dieta sana ed equilibrata e un'adeguata attività fisica.

Join Jennie Berkovich, DO, as she interviews Natalie Zelenko, MD, to discuss the vital topic of breast cancer screening. Together, they explore the latest guidelines on when women should begin routine mammograms, how technology has advanced to improve early detection, and the differences between screening and diagnostic mammograms. Dr. Zelenko breaks down what happens after an abnormal mammogram, the role of biopsies, and how breast MRIs compare to traditional imaging. They also delve into the impact of genetics, family history, and risk factors on screening decisions, offering a comprehensive look at modern breast cancer detection and prevention. Don't miss this empowering and informative conversation! With over 15 years of experience in the field of breast imaging, Dr. Natalie Zelenko is a skilled and compassionate physician dedicated to providing exceptional care for her patients.  She specializes in high-risk breast cancer screening and breast cancer diagnosis, utilizing multimodality imaging and advanced breast interventional techniques to offer a comprehensive approach to regular surveillance and early detection.  Dr. Zelenko's expertise spans a range of breast imaging modalities, including mammography, digital tomosynthesis, ultrasound, breast MRI, and minimally invasive image-guided biopsy techniques, allowing her to provide tailored, evidence-based care for each patient.  Taking a warm yet firm approach to building strong relationships with her patients Dr. Zelenko creates a supportive environment where the patients feel heard and informed. Her patients appreciate her clear communication and dedication to helping them navigate complex diagnostic and treatment decisions with confidence. Dr. Zelenko is deeply committed to multidisciplinary patient care, collaborating closely with breast surgeons, medical and radiation oncologists, pathologists, as well as other healthcare professionals to ensure each patient receives the most comprehensive approach.As an advocate for breast health awareness, Dr. Zelenko is actively involved in community education initiatives, speaking at local events and participating in outreach programs to educate the public on the importance of regular screening and early detection.Dr. Zelenko received her medical degree from Cornell University Medical College and completed her residency in Diagnostic Radiology as well as fellowship in Breast Imaging at Maimonides Medical Center. She is board-certified in Diagnostic Radiology and is a fellow of the American College of Radiology, maintaining memberships in the Radiological Society of North America, Society of Breast Imaging & European Society of Radiology. Dr. Zelenko is dedicated to staying at the forefront of her field, attending numerous leading medical conferences in the United States & abroad. She is committed to continued learning, ensuring that her patients receive the most advanced and up-to-date care possible. Sponsor the JOWMA Podcast! Email digitalcontent@jowma.org Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter! www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

ByteDance and TikTok filed an emergency motion on Monday asking an appeals court to temporally block the law that would ban TikTok in the U.S. unless the social network divests from Chinese ownership by January 19. Also, Apple is being sued over its decision not to implement a system that would have scanned iCloud photos for child sexual abuse material (CSAM). The lawsuit argues that by not doing more to prevent the spread of this material, it's forcing victims to relive their trauma, according to The New York Times; A U.S. breast-screening program claims to demonstrate the potential benefits of using artificial intelligence (AI) in mammography screening, with women who paid for AI-enhanced scans 21% more likely to have cancer detected. DeepHealth, an AI firm owned by radiology giant RadNet, presented its findings at the annual meeting of the Radiological Society of North America; When it comes to market capitalization, Nvidia is currently the second-biggest public company in the world, behind Apple. That's why all eyes are on Nvidia these days. And now, as Bloomberg spotted, China Central Television, a public TV broadcaster, is reporting that China's market regulator has opened a probe into Nvidia's acquisition of Mellanox; Nikola Corp., a producer of battery and hydrogen-electric trucks, has taken several steps to repay its debts and raise equity, including offering up to $100 million in a common stock sale.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Could your favorite snack be silently sabotaging your fitness goals? Recent research from the Radiological Society of North America's annual meeting reveals a hidden threat to your muscle health and mobility: ultra-processed foods. These convenient yet cunning snacks may be causing fat to infiltrate your muscle fibers, undermining your strength and potentially leading to conditions like knee osteoarthritis. Even the most disciplined gym-goers and diet-watchers aren't safe from the sneak attack of these addictive combinations of sugar, fat, and salt. We break down the science behind these findings and equip you with practical strategies to resist the allure of ultra-processed foods, from making smarter choices at the store to embracing healthier snack alternatives.But it's not all bad news—there's hope in whole foods. We share tangible tips to help you weave more nutrient-dense options into your daily routine without feeling deprived. Meal prepping becomes your ally as we guide you through preparing veggies and grains in advance, paving the way for a flexible and fun "build your own meal" system. With ideas for delicious, easy recipes like roasted veggies and smoothies, we emphasize the importance of progress over perfection. Small steps toward incorporating whole foods can lead to profound impacts on your health, setting a strong foundation for a thriving future. Join us as we chart a path toward a healthier tomorrow, one meal at a time.Support the show✅ Support my work on Venmo , Yappy or PayPal✅ Check out my Linktr.ee

Karena Galvin, Deputy Executive Director of The Radiological Society of North America, joins Jon Hansen on Your Money Matters. The two discuss the convention and their 110th meeting this year, 85 of those times have been in Chicago. The show is a vital platform for unveiling groundbreaking technologies and innovations in radiology, impacting healthcare systems […]

Dr. Ebrahim Kader, a Partner at Morton & Partners, is a distinguished radiologist with an extensive background in Neuroradiology and Neuro- and General Interventional Radiology. He completed his undergraduate and post graduate training at the University of Cape Town (UCT) and has earned multiple prestigious awards. An MSc graduate from University of Paris, Dr Kader is the Past President of the Radiological Society of South Africa, vice president of the SA Society of Neuroradiology and a member of the National Angels Stroke Steering committee.  His interest in diagnosis and treatment of stroke has led him to be actively involved in establishing stroke treatment SA.See omnystudio.com/listener for privacy information.

Leslie is joined by Dr. Nicole Saphier, who has served as a FOX News Channel contributor since 2018, breaking down the latest medical news across all platforms. Dr. Saphier is a board-certified radiologist with advanced fellowship training in breast imaging.   The two ladies discuss Breast Cancer Awareness month, which is right around the corner in October, and what folks can do to protect themselves and their families from the dangerous disease. Then, the pair comments on a new study linking social media to eating disorders in kids and young teens. Dr. Saphier is author of FOX News Books' best-seller "Love, Mom," which shines a light on maternal love with powerful first person stories from the FOX News family and beyond. In addition to her clinical, research and media responsibilities, Dr. Saphier holds leadership and advisory positions at the Centers for Disease Control & Prevention, New Jersey Department of Health, and Radiological Society of New Jersey. Her website is www.NicoleSaphierMD.com and her handle on X is @NBSaphierMD.

Leslie is joined by Dr. Nicole Saphier, who has served as a FOX News Channel contributor since 2018, breaking down the latest medical news across all platforms. Dr. Saphier is a board-certified radiologist with advanced fellowship training in breast imaging.   The two ladies discuss Breast Cancer Awareness month, which is right around the corner in October, and what folks can do to protect themselves and their families from the dangerous disease. Then, the pair comments on a new study linking social media to eating disorders in kids and young teens. Dr. Saphier is author of FOX News Books' best-seller "Love, Mom," which shines a light on maternal love with powerful first person stories from the FOX News family and beyond. In addition to her clinical, research and media responsibilities, Dr. Saphier holds leadership and advisory positions at the Centers for Disease Control & Prevention, New Jersey Department of Health, and Radiological Society of New Jersey. Her website is www.NicoleSaphierMD.com and her handle on X is @NBSaphierMD.

See all the Healthcasts at https://www.biobalancehealth.com/healthcast-blog That is a strong statement, however I am confident in saying that belly fat can put you at risk for Alzheimer's disease, because it is a fact supported by medical research. These studies reveal that obesity, especially abdominal obesity (Beer belly, Gut, “Dunlap's disease”…..), increases the onset and rate of Alzheimer's dementia! Another reason to change your lifestyle to benefit your longevity. Abdominal obesity can come from fat accumulation right underneath your skin (the fat you can pinch between 2 fingers) OR the fat that grows inside your abdomen like an apron draped over the intestines. It is called “visceral fat”, and this type of fat is what places you in the crosshairs for several diseases of aging including Alzheimer's Disease, heart disease, stroke, diabetes, and rapid aging.  A large belly is more common in men, but it is still a risk for women if they develop an apple shaped body. Below is a picture of visceral fat, and a diagram of what it looks like in an artist's sketch of a normal weight person. When the yellow fat doubles and triples in thickness the abdomen pushes out to look like a “beer belly”.   Visceral fat extends from your stomach over the transverse colon and your small intestines like an apron.  This fat pad thickens with alcohol abuse (beer belly), high carbohydrate diet, overeating, junk food, under exercise and creates a large pad of fat that secretes inflammatory cells.  The resulting inflammation is the vehicle that damages your brain leading to Alzheimer's disease and damages your arteries leading to heart disease and stroke. In my office we use INBODY machines that measure your Visceral fat, BMI, and percent body fat.  Normal visceral fat is below #10 on our machine, BMI less than or equal to 25, and fat % for men < 19% and for women < 26%. The Research: A recent study correlated the size of patient's belly (visceral belly fat), and obesity with the amount of amyloid plaque (the cause of Alzheimer's disease) in their brain. This was measured by MRI in the study subjects' brains.  The age of the patients studied was between 40-60. The study found that the amount of visceral fat (fat inside your abdomen) is directly correlated with the amount of amyloid plaque and inflammation in the brain!  That causes Alzheimer's Disease. If that doesn't motivate you to lose your belly fat, then you are making a choice to eventually suffer from Alzheimer's disease, a heart attack, a stroke or arthritis.  If you are thinking that you will just wait for “something to happen”, then not making a decision to change your lifestyle is making a decision to take on illness in the future. We have new medications to help you lose that belly fat and they really work. You should ask your doctor to help you and if they don't understand the importance of arriving at ideal weight then look for a different doctor who will help you. Even with medication you will have to put in the work and self-control to turn down unhealthy foods when others are being unhealthy.  You will also have to add daily exercise to your schedule if you really want to avoid Alzheimer's Disease, heart attack, stroke and early death. The possible meds and habits that can help you lose your “belly”: ·     Limit calories and or carbohydrates ·     Increase daily exercise ·     Diet pills (amphetamines that older patients usually can't take) ·     Xenical (Orlistat)-Side effect is fatty diarrhea ·     Qsymia (topiramate/Phentermine) can increase BP ·     Contrave for craving (naltrexone/bupropion) can decrease sex-drive ·     Semelanotide (Imcivree-new), darkens the skin, expensive ·     Metformin ER an oral, effective medication to treat insulin resistance, and promote weight-loss ·     Victoza and Saxenda injections are diabetic treatments, that can cause GI reflux, however they work well for patients who have Type II Diabetes who need to lose weight. Even though many patients lost weight with these medications, many could not tolerate the drugs listed above because of the side effects.  These side effects limited our ability to help all patients lose weight…until now! Now, for the first time we have an effective way to help most people lose their dangerous visceral (belly fat). If you have a big belly you are at high risk for inflammatory diseases like Alzheimer's dementia, obesity, heart disease, diabetes, cancer and stroke. The new weight loss drug's generic name is Semaglutide, and has been marketed under several names: Wegovy, Ozempic, and Rybelsus. A second generic drug that is in the same family of drugs is called Tirzepetide, includes Mounjaro (for diabetics) and Zepbound (for weight loss). All of these drug's work for weight loss, pre-diabetes and Type 2 Diabetes.  Most insurance companies do not cover weight loss and they require a precertification for you to get the medication covered by insurance.  This precertification process is time consuming for the doctor and her staff, which costs the doctor an increase in her overhead to employ a nurse to provide this service for the patient. In general people with a BMI under 30 will not be covered for Semaglutide or Tirzapeptide, however if their BMI is over 30, there is a chance insurance will pay for one of these drugs for a period of time. The market price at the pharmacy is between $900/$1200 per month if you pay out of pocket to your pharmacy. Because of this fact and because we have so many patients whose pellets are not paid for by insurance, we provide access to the generic form of these drugs through a compounding pharmacy. The cost is a fraction of the normal out of pocket cost, about $560 for 3 months supply. In this way we have been able to treat many people who cannot afford to pay the exorbitant going rate for this medication. Because it is costly for a patient to receive the medication no matter how they are able to get it, It is very important for weight loss patients to be compliant and follow a low carbohydrate diet, exercise daily and to refrain from alcohol consumption while they are taking weight loss medications.  We require our patients who request these drugs to be seen at least every 2 months by one of our NPs or our weight loss specialist to help them get the best results possible. These drugs work for weight loss and diabetes by multitasking.  The ways the medication actually works are listed below: Semaglutide and Terzapeptide, ·      decrease hunger between meals   ·     you feel full faster than normal so you eat less ·     decrease sugar and alcohol-craving ·     decrease the release of sugar from the liver when you are fasting, which turns into fat ·     Prevent hypoglycemia which causes hunger and fat gain ·     Makes patients more insulin sensitive. Obesity is not just a lifestyle problem; it is a disease that should be treated with medicine PLUS lifestyle changes. These drug actions take place in the brain, stomach hormones, pancreas and liver, as well as in all the cells in your body. At Bio Balance Health® have years of experience in treating patients with bio-identical testosterone pellets and we have observed that weight loss plus testosterone pellets for patients over 40 allows patients to lose fat without losing muscle. Now we add these weight loss medications to T pellets, and we have the perfect combo for safe weight-loss (really fat loss). The biggest worry for patients is that they may not be able to get off this drug after they achieve ideal weight.  I have found that the longer you have been overweight and the more overweight you are, the higher the risk of needing maintenance medications to maintain your ideal weight. We try to wean our patients off injectable meds by switching them to Metformin ER, a drug that insurance will pay for. With these effective meds we finally, we have an effective preventive treatment to add to our testosterone and estradiol pellets for those people who view Alzheimer's as their worst nightmare, and for those patients who are worried about heart disease, diabetes and stroke  we can prevent the diseases that can ruin our “golden years”.   KCM Research: People with large amounts of visceral fat as they age may have higher risk of Alzheimer's disease. NBC News (11/20, Carroll) reports, “People who have large amounts of” visceral fat “as they age may be at higher risk of developing Alzheimer's disease, a new study suggests.” The findings were presented at the Radiological Society of North America's annual meeting. HealthDay (11/20, Thompson) reports that investigators “compared brain scans of 54 people between the ages of 40 and 60 with their levels of belly fat, BMI, obesity and insulin resistance.” The investigators “found that people who had more visceral fat compared with fat found just under their skin tended to have higher amyloid levels in the precuneus cortex.” The “relationship was worse in men than in women, and higher visceral fat measurements also were related to increased inflammation in the brain.”

Let's listen to this new episode!

(AURN News) – Important new research presented at the Annual Meeting of the Radiological Society of North America this week highlights a significant racial disparity in the timing of an Alzheimer's disease diagnosis and access to imaging. The study, led by Dr. Joshua Wibecan, a radiology resident at Boston Medical Center, sheds light on the challenges faced by Black Americans in receiving timely diagnoses for Alzheimer's and other forms of dementia. "If disparity in obtaining access to neuroimaging is one possible barrier that delays diagnosis, it is important to identify this and figure out possible solutions to benefit these patients and prevent a delayed diagnosis," Dr. Wibecan said in a statement. According to the findings, Black Americans face a higher risk of Alzheimer's and various dementia types. The study shows that the Black community is not only less likely to receive a diagnosis but also experiences delays compared to their white counterparts. The research revealed striking differences in the age at which imaging services were utilized among various ethnic groups. On average, African American patients underwent imaging at 72.5 years old, compared to 67.8 years old for white patients and 66.5 years old for Hispanic patients. Additionally, the study found that only 50.9% of Black patients underwent MRI scans, while 60% of white patients and 67% of Hispanic patients received the same diagnostic procedure. Learn more about your ad choices. Visit megaphone.fm/adchoices

STUDY SAYS AI BETTER AT PREDICTING CANCER RISK A new study claims that artificial intelligence is more accurate at predicting a patient's cancer risk than traditional methods.  Artificial intelligence (AI) programs performed better at predicting five-year breast cancer risk than traditional models, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA).  The researchers used data from negative 2d mammograms performed at Kaiser Permanente Northern California in 2016.  The scientists screened 324,009 women and chose 13,628 for analysis. In addition, 4,584 from the eligibility pool diagnosed with breast cancer within five years of the original 2016 mammogram remained in the study.  The scientists followed the participants until 2021.  See omnystudio.com/listener for privacy information.

This week we talked with Rubén García about the convention of the Radiological Society of Puerto Rico (SOCRAD) and our experience in this event.For more information: https://diss.com/podcast/socrad-2023-our-experience/

S2E20: We Can But Should We with Richard Duszak, MD, Professor and Chair, Dept of Radiology, University of Mississippi Medical Center and host Dr. Nick. The largest gatherings in radiology in the world is The Radiological Society of North America (RSNA). It is always the same time each year, immediately following Thanksgiving in Chicago touting the latest and greatest updates in radiology from science and technology. Now attendance is coming in the shadow of the Pandemic experience that shone a spotlight on our system that is failing so many and in some fundamentally inequitable ways. Investment decisions are difficult and no matter what facility or role you work in, resources are limited. We need to expand access and serve the whole population equally. As you will hear Rich say we have to have hard conversations and ask ourselves and our colleagues “should we be doing these things”. Your better pill to swallow is to learn to say no. No to projects. No to investments. No to anything that is not serving the patient in the delivery of fair, equitable, and compassionate healthcare. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio.” Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Video Link --> https://youtu.be/hgnq4zy1ivEZone3Podcast and the gang happy to be joined by Dr. Joanna Shechtel, MD. Dr Shechtel earned her medical degree from Georgetown University. She completed a residency in Diagnostic Radiology at University of Tennessee - Knoxville, where she served as Chief Resident, and a fellowship in Musculoskeletal Imaging at Vanderbilt University Medical Center (VUMC). In 2021, Dr. Shechtel joined VUMC faculty as an Assistant Professor of Clinical Radiology in the Musculoskeletal Radiology section. She is a member of the Radiological Society of North America, American Roentgen Ray Society, American College of Radiology, Tennessee Medical Association and Nashville Academy of Medicine. Dr. Shechtel's clinical interests include MRI safety, quality improvement and resident education. Dr. Shechtel main area of expertise is sarcomas as it pertains to MSK Diagnostic Imaging. Sarcomas are rare cancers that develop in the bones and soft tissues, including fat, muscles, blood vessels, nerves, deep skin tissues and fibrous tissues. There are many risk factors for sarcomas. History of radiation therapy, genetic predisposition and chemical exposure. Imaging properties include size, adjacent tissue differences, infiltrating and contrast enhancement. She was first introduced to the importance of MRI safety by Dr. Peter Petruzzi, MRMD during her residency. She credits Dr. Shellock for her choice to later become a board member of ABMRS.Many factors to consider for sarcoma imaging. coils, image planes, patient positioning, FOV, phase direction, technique, sequence selection etc. Dr. Shechtel doesn't have a preference in field strength if imaging quality isn't compromised. Duplicating a prior study is also a consideration and should be the goal absent of contraindication. High resolution imaging is her preference over small FOV imaging if forced to decide between the two. She stresses the importance of Surgeon preference consideration with joint-to-joint imaging. Prothesis may be in that patient's course of care. Large FOV imaging allows for pre-op measurements as well as visualization of skip lesions. We always love it when our guests come prepared with helpful visual aids. Dr. Shechtel brings imaging examples which help illustrate her case in point. It was a joy spending with someone of Dr. Shechtel's caliber.

Are you a CBCT user?  Do you have concerns regarding reading of CBCTs?  This episode will help you in your reading and potentially reduce your liability.  This team of MDs work closely with DentalRay to read your CBCTs. They will be sharing findings from actual dental images and their knowledge as to how we can become better diagnosticians.  We are really excited about this episode.  We have learned so much from Dr. Brown and can't wait to hear from Dr. Mehta.  Following the episode, there will be a special promotion from DentalRay!About Dr. Brown:Dr. Brown is a practicing neuroradiologist who completed residency and fellowship training at UCSF, developing advanced skills in brain, maxillofacial, head/neck, and spine imaging as well as minimally invasive spine and pain procedures.  He holds a Doctor of Medicine from Georgetown University. In addition to his clinical training, Dr. Brown holds a PhD in molecular biology, completing his doctoral work at the National Institutes of Health, efforts that led to many peer-reviewed publications and grant funding from the Radiological Society of North America. His research interests focus on advancing precision pain medicine and image-guided pain interventions.Dr. Brown is Co-founder and Chief Medical Officer of DentalRay, a nationwide platform providing comprehensive radiology services to dental professionals.About Dr. Mehta:Dr. Mehta is a practicing neuroradiologist who completed residency and fellowship training at UTSW, developing advanced skills in brain, maxillofacial, head/neck, and spine imaging as well as minimally invasive spine and pain procedures.  She holds a Doctor of Medicine from George Washington University. She served as chief resident while in training at UT Southwestern with particular interest in medical education. Her research and extracurricular interests focus on developing educational materials and utilizing innovative techniques to advance medical knowledge. Her professional associations include the Radiological Society of North America, American College of Radiology and American Society of Neuroradiology.This episode is brought to you by DentalRay.

Obesity might harm the brain health of children and adolescents. According to a new study presented at the annual meeting of the Radiological Society of North America, researchers collected and analyzed data from the Adolescent Brain Cognitive Development study, including over 5,000 children 9 to 10 years old. They measured each child's body mass index […] The post 331. Higher weight in childhood is associated with poor brain health appeared first on Dr. David Geier - Feel and Perform Better Than Ever.

Join AXIS Imaging News Chief Editor Keri Stephens as she talks to Tracy Byers, senior vice president and general manager of enterprise imaging at Change Healthcare. The in-person interview, conducted at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, delves into all things enterprise imaging and why cloud-native solutions are especially beneficial. Particularly, Byers shares the impetus behind Change Healthcare's introduction of Stratus Cloud PACS and the cybersecurity implications of the launch. After all, Byers maintains, hospital chief information officers lie awake at night wondering when—not if—they're going to get hacked.

Die Themen in den Wissensnachrichten: +++ Rhesusaffen haben im Alter weniger Freunde +++ System für selbstparkende Autos am Stuttgarter Flughafen +++ Fledermäuse können Death-Metal-Töne erzeugen +++ **********Weiterführende Quellen zu dieser Folge:Within-individual changes reveal increasing social selectivity with age in rhesus macaques/ PNAS, 29.11.22Radiology Weather Forecast: Prediction of Average Versus Above Average Polytrauma-CT Occurrence Based on Weather Data/ 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America, 30.11.22A Glaring Absence: The Climate Crisis is Virtually Nonexistent in Scripted Entertainment/ USC Norman Lear Center Media Impact Project, 30.11.22Weltpremiere am Flughafen Stuttgart: Fahrerloses Parksystem von Bosch und Mercedes-Benz erhält Genehmigung für Serieneinsatz/ Stuttgart Airport, 30.11.22Seventeenth session of the Intergovernmental Committee for the Safeguarding of the Intangible Cultural Heritage/ Unesco, 30.11.22Bats expand their vocal range by recruiting different laryngeal structures for echolocation and social communication/ PLOS Biology, 29.11.22**********Ihr könnt uns auch auf diesen Kanälen folgen: Tiktok und Instagram.**********Weitere Wissensnachrichten zum Nachlesen: https://www.deutschlandfunknova.de/nachrichten

Dr. Mark Mullins is a neuroradiologist and professor Department of Radiology and Imaging Sciences at Emory University. In addition to his clinical responsibilities, he also serves as the Vice-chair for education within the department and as well as the Director of Radiology Medical Student Education. Prior to joining the faculty at Emory, Dr. Mullins completed his undergraduate and graduate training in chemistry at Harvard University and his medical education as part of the Harvard MIT program in Health Sciences and Technology. He then completed his diagnostic radiology residence and neuroradiology fellowship at Massachusetts General Hospital. Since joining the faculty at Emory, Dr. Mullins has remained actively involved with medical education, including having previously served as the diagnostic radiology residency program director. He also holds numerous teaching and mentorship awards received throughoutthe years, including the 2020 Radiological Society of North America's Outstanding Educator Award. In today's episode, we discuss several important educational initiatives of his during his time at Emory, including the creation of the Emory research-track residency program. We also discuss important transitions throughout/phd and physician-scientist training. Credits: Our thanks to Dr. Mullins for being on the podcast. Follow Dr. Mullins on twitter: @markemullins Dr. Mullins' faculty page: https://winshipcancer.emory.edu/bios/faculty/mullins-mark-e.html Host: Bejan Saeedi Co-Host and Audio Engineer – Joe Behnke Executive Producer and Social Media Coordinator – Carey Jansen Executive Producer – Michael Sayegh Associate Producer – Josh Owens Faculty Advisor – Dr. Brian Robinson Twitter: @behindthescope_ Instagram: @behindthemicroscopepod Facebook: @behindthemicroscope1 Website: behindthemicroscope.com

This special Voices AMplified podcast features guest host Bryan Crutchfield, vice-president and general manager at Materialise and an advisor for SME's AM Technical Community Leadership Committee, and Andy Christensen, adjunct faculty in the radiology department at the University of Cincinnati, as well as the 2022 chair of the Radiological Society of North America's 3D Printing Special Interest Group for Medical Devices, a Fellow of the SME and AMUG, and recipient of SME's AM Achievement Award in 2009. Crutchfield and Christensen discuss in-depth the promise and challenges AM for medical.

Benjamin Pulli, MD, is a fellowship trained interventional neuroradiologist with a focus on vascular disorders of the brain, head/neck, and spine. He employs state-of-the-art minimally invasive endovascular and percutaneous surgical techniques to treat patients with intracranial aneurysms, acute stroke, brain arteriovenous malformations, dural arteriovenous fistulas, tumors, and chronic back pain. Having grown up in Austria, Dr. Pulli moved to the US after completing medical school in Innsbruck, Austria. He completed post-doctoral research training in Neuroradiology and Molecular Imaging at Harvard Medical School, followed by a Radiology residency and Neuroradiology fellowship training at the Massachusetts General Hospital in Boston. He then completed a second fellowship in Interventional Neuroradiology/Endovascular Neurosurgery at Stanford University. Dr. Pulli has authored more than 40 peer-reviewed publications and received prestigious scientific grants from institutions such as the Radiological Society of North America and Ernst Schering Foundation. To learn more about Dr. Pulli and other PNI Doctors please visit https://www.pacificneuroscienceinstitute.org/about-us/our-team/

In today's ever changing event world, it's critical to figure out new ways for exhibitors to reach their target audience. To give tips and advice is Erica Bishaf - the Founder & CEO of CampfireSocial, the first-of-its-kind private social network and commerce platform designed for trade verticals. Erica is a 20+ year award winning strategy & insights veteran who has worked for consumer packaged goods companies such as Kraft, Nestle, Kimberly-Clark, & MillerCoors and through her consulting business she worked on strategy projects for associations & event organizers including Freeman, GES, the American Library Association, the Audiovisual and Integrated Experience Association (AVIXA), the Radiological Society of North America (RSNA), the National Retail Federation (NRF), and more. In this episode we discuss: Generating leads through virtual platforms such as communities, marketplaces, and virtual events How exhibitors can maximize their reach when on a virtual platform Tactics to deploy on communities vs. marketplaces vs. virtual events Erica's Top Takeaways: Content marketing and relationship building tactics will produce more leads and stickier customers. The modern digital audience is more receptive to slow and steady - building relationships over time. Digital platform marketing requires strategy and exhibitors/sponsors should be dedicating the time to formulating in order to maximize their investment Exhibitors should not accept low ROI from their show organizers and should speak up asking for better tools and more support. Contact Erica Bishaf: Email: erica.bishaf@campfiresocial.io Website: https://www.campfiresocial.io/ Phone: 312.350.5270 Don't Miss an Episode!! Subscribe to Trade Show University at your favorite podcast platform like Apple, Google, Spotify, Stitcher, Amazon, Gaana and more! Get Top 52 Trade Show Tips - go to tradeshowu.biz

REFERÊNCIAS1.Pontone G, Scafuri S, Mancini ME, Agalbato C, Guglielmo M, Baggiano A, et al. Role of computed tomography in COVID-19. J Cardiovasc Comput Tomogr. 2021;15(1):27-36.2.Cereser L, Da Re J, Zuiani C, Girometti R. Chest high-resolution computed tomography is associated to short-time progression to severe disease in patients with COVID-19 pneumonia. Clin Imaging. 2021;70:61-6.3.Hochhegger B, Mandelli NS, Stuker G, Meirelles GSP, Zanon M, Mohammed TL, et al. Coronavirus Disease 2019 (COVID-19) Pneumonia Presentations in Chest Computed Tomography: A Pictorial Review. Curr Probl Diagn Radiol. 2021;50(3):436-42.4.Besutti G, Ottone M, Fasano T, Pattacini P, Iotti V, Spaggiari L, et al. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room. Eur Radiol. 2021.5.Mogami R, Lopes AJ, Araujo Filho RC, de Almeida FCS, Messeder A, Koifman ACB, et al. Chest computed tomography in COVID-19 pneumonia: a retrospective study of 155 patients at a university hospital in Rio de Janeiro, Brazil. Radiol Bras. 2021;54(1):1-8.6.Cau R, Falaschi Z, Pasche A, Danna P, Arioli R, Arru CD, et al. CT findings of COVID-19 pneumonia in ICU-patients. J Public Health Res. 2021.7.Kanne JP, Bai H, Bernheim A, Chung M, Haramati LB, Kallmes DF, et al. COVID-19 Imaging: What We Know Now and What Remains Unknown. Radiology. 2021;299(3):E262-E79.8.Pourhoseingholi MA, Jafari R, Jafari NJ, Rahimi-Bashar F, Nourbakhsh M, Vahedian-Azimi A, et al. Predicting 1-year post-COVID-19 mortality based on chest computed tomography scan. J Med Virol. 2021;93(10):5694-6.9.Kato S, Ishiwata Y, Aoki R, Iwasawa T, Hagiwara E, Ogura T, et al. Imaging of COVID-19: An update of current evidences. Diagn Interv Imaging. 2021;102(9):493-500.10.Ozer H, Kilincer A, Uysal E, Yormaz B, Cebeci H, Durmaz MS, et al. Diagnostic performance of Radiological Society of North America structured reporting language for chest computed tomography findings in patients with COVID-19. Jpn J Radiol. 2021;39(9):877-88.11.Ramanan RV, Joshi AR, Venkataramanan A, Nambi SP, Badhe R. Incidental chest computed tomography findings in asymptomatic Covid-19 patients. A multicentre Indian perspective. Indian J Radiol Imaging. 2021;31(Suppl 1):S45-S52.12.Axiaq A, Almohtadi A, Massias SA, Ngemoh D, Harky A. The role of computed tomography scan in the diagnosis of COVID-19 pneumonia. Curr Opin Pulm Med. 2021;27(3):163-8.13.Ishfaq A, Yousaf Farooq SM, Goraya A, Yousaf M, Gilani SA, Kiran A, et al. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis. Eur J Radiol Open. 2021;8:100350.14.Razek A, Fouda N, Fahmy D, Tanatawy MS, Sultan A, Bilal M, et al. Computed tomography of the chest in patients with COVID-19: what do radiologists want to know? Pol J Radiol. 2021;86:e122-e35.15.Revel MP, Boussouar S, de Margerie-Mellon C, Saab I, Lapotre T, Mompoint D, et al. Study of Thoracic CT in COVID-19: The STOIC Project. Radiology. 2021;301(1):E361-E70.16.Au-Yong I, Higashi Y, Giannotti E, Fogarty A, Morling JR, Grainge M, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiology. 2021:210986.17.Little BP. Disease Severity Scoring for COVID-19: A Welcome (Semi)Quantitative Role for Chest Radiography. Radiology. 2021:212212.18.Prokop M, van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stoger L, Beenen L, et al. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020;296(2):E97-E104.19.Ozel M, Aslan A, Arac S. Use of the COVID-19 Reporting and Data System (CO-RADS) classification and chest computed tomography involvement score (CT-IS) in COVID-19 pneumonia. Radiol Med. 2021;126(5):679-87.20.Byrne D, Neill SBO, Muller NL, Muller CIS, Walsh JP, Jalal S, et al. RSNA Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19: Interobserver Agreement Between Chest Radiologists. Can Assoc Radiol J. 2021;72(1):159-66.21.Fonseca E, Loureiro BMC, Strabelli DG, Farias LPG, Garcia JVR, Gama VAA, et al. Evaluation of the RSNA and CORADS classifications for COVID-19 on chest computed tomography in the Brazilian population. Clinics (Sao Paulo). 2021;76:e2476.22.Barisione E, Grillo F, Ball L, Bianchi R, Grosso M, Morbini P, et al. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems. Virchows Arch. 2021;478(3):471-85.23.Kianzad A, Meijboom LJ, Nossent EJ, Roos E, Schurink B, Bonta PI, et al. COVID-19: Histopathological correlates of imaging patterns on chest computed tomography. Respirology. 2021;26(9):869-77.24.Aesif SW, Bribriesco AC, Yadav R, Nugent SL, Zubkus D, Tan CD, et al. Pulmonary Pathology of COVID-19 Following 8 Weeks to 4 Months of Severe Disease: A Report of Three Cases, Including One With Bilateral Lung Transplantation. Am J Clin Pathol. 2021;155(4):506-14.25.De Cobelli F, Palumbo D, Ciceri F, Landoni G, Ruggeri A, Rovere-Querini P, et al. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021.26.Vlachou M, Drebes A, Candilio L, Weeraman D, Mir N, Murch N, et al. Pulmonary thrombosis in Covid-19: before, during and after hospital admission. J Thromb Thrombolysis. 2021;51(4):978-84.27.Caruso D, Guido G, Zerunian M, Polidori T, Lucertini E, Pucciarelli F, et al. Postacute Sequelae of COVID-19 Pneumonia: 6-month Chest CT Follow-up. Radiology. 2021:210834.28.Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299(1):E177-E86.29.Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. CT of Post-Acute Lung Complications of COVID-19. Radiology. 2021:211396.30.Wells AU, Devaraj A, Desai SR. Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties. Radiology. 2021;299(1):E216-E8.31.Han X, Fan Y, Alwalid O, Zhang X, Jia X, Zheng Y, et al. Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19. Radiology. 2021:210972.32.Lindahl A, Reijula J, Malmberg LP, Aro M, Vasankari T, Makela MJ. Small airway function in Finnish COVID-19 survivors. Respir Res. 2021;22(1):237.33.Small Airways Disease is a Post-Acute Sequelae of SARS-CoV-2 Infection [Internet]. 2021.34.Lopes AJ, Mafort TT, da Cal MS, Monnerat LB, Litrento PF, Ramos I, et al. Impulse Oscillometry Findings and Their Associations With Lung Ultrasound Signs in COVID-19 Survivors. Respir Care. 2021.35.Wells AU, Devaraj A. Residual Lung Disease at 6-month Follow-up CT after COVID-19: Clinical Significance Is a Key Issue. Radiology. 2021:211284.

REFERÊNCIAS1.Pontone G, Scafuri S, Mancini ME, Agalbato C, Guglielmo M, Baggiano A, et al. Role of computed tomography in COVID-19. J Cardiovasc Comput Tomogr. 2021;15(1):27-36.2.Cereser L, Da Re J, Zuiani C, Girometti R. Chest high-resolution computed tomography is associated to short-time progression to severe disease in patients with COVID-19 pneumonia. Clin Imaging. 2021;70:61-6.3.Hochhegger B, Mandelli NS, Stuker G, Meirelles GSP, Zanon M, Mohammed TL, et al. Coronavirus Disease 2019 (COVID-19) Pneumonia Presentations in Chest Computed Tomography: A Pictorial Review. Curr Probl Diagn Radiol. 2021;50(3):436-42.4.Besutti G, Ottone M, Fasano T, Pattacini P, Iotti V, Spaggiari L, et al. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room. Eur Radiol. 2021.5.Mogami R, Lopes AJ, Araujo Filho RC, de Almeida FCS, Messeder A, Koifman ACB, et al. Chest computed tomography in COVID-19 pneumonia: a retrospective study of 155 patients at a university hospital in Rio de Janeiro, Brazil. Radiol Bras. 2021;54(1):1-8.6.Cau R, Falaschi Z, Pasche A, Danna P, Arioli R, Arru CD, et al. CT findings of COVID-19 pneumonia in ICU-patients. J Public Health Res. 2021.7.Kanne JP, Bai H, Bernheim A, Chung M, Haramati LB, Kallmes DF, et al. COVID-19 Imaging: What We Know Now and What Remains Unknown. Radiology. 2021;299(3):E262-E79.8.Pourhoseingholi MA, Jafari R, Jafari NJ, Rahimi-Bashar F, Nourbakhsh M, Vahedian-Azimi A, et al. Predicting 1-year post-COVID-19 mortality based on chest computed tomography scan. J Med Virol. 2021;93(10):5694-6.9.Kato S, Ishiwata Y, Aoki R, Iwasawa T, Hagiwara E, Ogura T, et al. Imaging of COVID-19: An update of current evidences. Diagn Interv Imaging. 2021;102(9):493-500.10.Ozer H, Kilincer A, Uysal E, Yormaz B, Cebeci H, Durmaz MS, et al. Diagnostic performance of Radiological Society of North America structured reporting language for chest computed tomography findings in patients with COVID-19. Jpn J Radiol. 2021;39(9):877-88.11.Ramanan RV, Joshi AR, Venkataramanan A, Nambi SP, Badhe R. Incidental chest computed tomography findings in asymptomatic Covid-19 patients. A multicentre Indian perspective. Indian J Radiol Imaging. 2021;31(Suppl 1):S45-S52.12.Axiaq A, Almohtadi A, Massias SA, Ngemoh D, Harky A. The role of computed tomography scan in the diagnosis of COVID-19 pneumonia. Curr Opin Pulm Med. 2021;27(3):163-8.13.Ishfaq A, Yousaf Farooq SM, Goraya A, Yousaf M, Gilani SA, Kiran A, et al. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis. Eur J Radiol Open. 2021;8:100350.14.Razek A, Fouda N, Fahmy D, Tanatawy MS, Sultan A, Bilal M, et al. Computed tomography of the chest in patients with COVID-19: what do radiologists want to know? Pol J Radiol. 2021;86:e122-e35.15.Revel MP, Boussouar S, de Margerie-Mellon C, Saab I, Lapotre T, Mompoint D, et al. Study of Thoracic CT in COVID-19: The STOIC Project. Radiology. 2021;301(1):E361-E70.16.Au-Yong I, Higashi Y, Giannotti E, Fogarty A, Morling JR, Grainge M, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiology. 2021:210986.17.Little BP. Disease Severity Scoring for COVID-19: A Welcome (Semi)Quantitative Role for Chest Radiography. Radiology. 2021:212212.18.Prokop M, van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stoger L, Beenen L, et al. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020;296(2):E97-E104.19.Ozel M, Aslan A, Arac S. Use of the COVID-19 Reporting and Data System (CO-RADS) classification and chest computed tomography involvement score (CT-IS) in COVID-19 pneumonia. Radiol Med. 2021;126(5):679-87.20.Byrne D, Neill SBO, Muller NL, Muller CIS, Walsh JP, Jalal S, et al. RSNA Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19: Interobserver Agreement Between Chest Radiologists. Can Assoc Radiol J. 2021;72(1):159-66.21.Fonseca E, Loureiro BMC, Strabelli DG, Farias LPG, Garcia JVR, Gama VAA, et al. Evaluation of the RSNA and CORADS classifications for COVID-19 on chest computed tomography in the Brazilian population. Clinics (Sao Paulo). 2021;76:e2476.22.Barisione E, Grillo F, Ball L, Bianchi R, Grosso M, Morbini P, et al. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems. Virchows Arch. 2021;478(3):471-85.23.Kianzad A, Meijboom LJ, Nossent EJ, Roos E, Schurink B, Bonta PI, et al. COVID-19: Histopathological correlates of imaging patterns on chest computed tomography. Respirology. 2021;26(9):869-77.24.Aesif SW, Bribriesco AC, Yadav R, Nugent SL, Zubkus D, Tan CD, et al. Pulmonary Pathology of COVID-19 Following 8 Weeks to 4 Months of Severe Disease: A Report of Three Cases, Including One With Bilateral Lung Transplantation. Am J Clin Pathol. 2021;155(4):506-14.25.De Cobelli F, Palumbo D, Ciceri F, Landoni G, Ruggeri A, Rovere-Querini P, et al. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021.26.Vlachou M, Drebes A, Candilio L, Weeraman D, Mir N, Murch N, et al. Pulmonary thrombosis in Covid-19: before, during and after hospital admission. J Thromb Thrombolysis. 2021;51(4):978-84.27.Caruso D, Guido G, Zerunian M, Polidori T, Lucertini E, Pucciarelli F, et al. Postacute Sequelae of COVID-19 Pneumonia: 6-month Chest CT Follow-up. Radiology. 2021:210834.28.Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299(1):E177-E86.29.Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. CT of Post-Acute Lung Complications of COVID-19. Radiology. 2021:211396.30.Wells AU, Devaraj A, Desai SR. Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties. Radiology. 2021;299(1):E216-E8.31.Han X, Fan Y, Alwalid O, Zhang X, Jia X, Zheng Y, et al. Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19. Radiology. 2021:210972.32.Lindahl A, Reijula J, Malmberg LP, Aro M, Vasankari T, Makela MJ. Small airway function in Finnish COVID-19 survivors. Respir Res. 2021;22(1):237.33.Small Airways Disease is a Post-Acute Sequelae of SARS-CoV-2 Infection [Internet]. 2021.34.Lopes AJ, Mafort TT, da Cal MS, Monnerat LB, Litrento PF, Ramos I, et al. Impulse Oscillometry Findings and Their Associations With Lung Ultrasound Signs in COVID-19 Survivors. Respir Care. 2021.35.Wells AU, Devaraj A. Residual Lung Disease at 6-month Follow-up CT after COVID-19: Clinical Significance Is a Key Issue. Radiology. 2021:211284.

REFERÊNCIAS1.Pontone G, Scafuri S, Mancini ME, Agalbato C, Guglielmo M, Baggiano A, et al. Role of computed tomography in COVID-19. J Cardiovasc Comput Tomogr. 2021;15(1):27-36.2.Cereser L, Da Re J, Zuiani C, Girometti R. Chest high-resolution computed tomography is associated to short-time progression to severe disease in patients with COVID-19 pneumonia. Clin Imaging. 2021;70:61-6.3.Hochhegger B, Mandelli NS, Stuker G, Meirelles GSP, Zanon M, Mohammed TL, et al. Coronavirus Disease 2019 (COVID-19) Pneumonia Presentations in Chest Computed Tomography: A Pictorial Review. Curr Probl Diagn Radiol. 2021;50(3):436-42.4.Besutti G, Ottone M, Fasano T, Pattacini P, Iotti V, Spaggiari L, et al. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room. Eur Radiol. 2021.5.Mogami R, Lopes AJ, Araujo Filho RC, de Almeida FCS, Messeder A, Koifman ACB, et al. Chest computed tomography in COVID-19 pneumonia: a retrospective study of 155 patients at a university hospital in Rio de Janeiro, Brazil. Radiol Bras. 2021;54(1):1-8.6.Cau R, Falaschi Z, Pasche A, Danna P, Arioli R, Arru CD, et al. CT findings of COVID-19 pneumonia in ICU-patients. J Public Health Res. 2021.7.Kanne JP, Bai H, Bernheim A, Chung M, Haramati LB, Kallmes DF, et al. COVID-19 Imaging: What We Know Now and What Remains Unknown. Radiology. 2021;299(3):E262-E79.8.Pourhoseingholi MA, Jafari R, Jafari NJ, Rahimi-Bashar F, Nourbakhsh M, Vahedian-Azimi A, et al. Predicting 1-year post-COVID-19 mortality based on chest computed tomography scan. J Med Virol. 2021;93(10):5694-6.9.Kato S, Ishiwata Y, Aoki R, Iwasawa T, Hagiwara E, Ogura T, et al. Imaging of COVID-19: An update of current evidences. Diagn Interv Imaging. 2021;102(9):493-500.10.Ozer H, Kilincer A, Uysal E, Yormaz B, Cebeci H, Durmaz MS, et al. Diagnostic performance of Radiological Society of North America structured reporting language for chest computed tomography findings in patients with COVID-19. Jpn J Radiol. 2021;39(9):877-88.11.Ramanan RV, Joshi AR, Venkataramanan A, Nambi SP, Badhe R. Incidental chest computed tomography findings in asymptomatic Covid-19 patients. A multicentre Indian perspective. Indian J Radiol Imaging. 2021;31(Suppl 1):S45-S52.12.Axiaq A, Almohtadi A, Massias SA, Ngemoh D, Harky A. The role of computed tomography scan in the diagnosis of COVID-19 pneumonia. Curr Opin Pulm Med. 2021;27(3):163-8.13.Ishfaq A, Yousaf Farooq SM, Goraya A, Yousaf M, Gilani SA, Kiran A, et al. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis. Eur J Radiol Open. 2021;8:100350.14.Razek A, Fouda N, Fahmy D, Tanatawy MS, Sultan A, Bilal M, et al. Computed tomography of the chest in patients with COVID-19: what do radiologists want to know? Pol J Radiol. 2021;86:e122-e35.15.Revel MP, Boussouar S, de Margerie-Mellon C, Saab I, Lapotre T, Mompoint D, et al. Study of Thoracic CT in COVID-19: The STOIC Project. Radiology. 2021;301(1):E361-E70.16.Au-Yong I, Higashi Y, Giannotti E, Fogarty A, Morling JR, Grainge M, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiology. 2021:210986.17.Little BP. Disease Severity Scoring for COVID-19: A Welcome (Semi)Quantitative Role for Chest Radiography. Radiology. 2021:212212.18.Prokop M, van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stoger L, Beenen L, et al. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020;296(2):E97-E104.19.Ozel M, Aslan A, Arac S. Use of the COVID-19 Reporting and Data System (CO-RADS) classification and chest computed tomography involvement score (CT-IS) in COVID-19 pneumonia. Radiol Med. 2021;126(5):679-87.20.Byrne D, Neill SBO, Muller NL, Muller CIS, Walsh JP, Jalal S, et al. RSNA Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19: Interobserver Agreement Between Chest Radiologists. Can Assoc Radiol J. 2021;72(1):159-66.21.Fonseca E, Loureiro BMC, Strabelli DG, Farias LPG, Garcia JVR, Gama VAA, et al. Evaluation of the RSNA and CORADS classifications for COVID-19 on chest computed tomography in the Brazilian population. Clinics (Sao Paulo). 2021;76:e2476.22.Barisione E, Grillo F, Ball L, Bianchi R, Grosso M, Morbini P, et al. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems. Virchows Arch. 2021;478(3):471-85.23.Kianzad A, Meijboom LJ, Nossent EJ, Roos E, Schurink B, Bonta PI, et al. COVID-19: Histopathological correlates of imaging patterns on chest computed tomography. Respirology. 2021;26(9):869-77.24.Aesif SW, Bribriesco AC, Yadav R, Nugent SL, Zubkus D, Tan CD, et al. Pulmonary Pathology of COVID-19 Following 8 Weeks to 4 Months of Severe Disease: A Report of Three Cases, Including One With Bilateral Lung Transplantation. Am J Clin Pathol. 2021;155(4):506-14.25.De Cobelli F, Palumbo D, Ciceri F, Landoni G, Ruggeri A, Rovere-Querini P, et al. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021.26.Vlachou M, Drebes A, Candilio L, Weeraman D, Mir N, Murch N, et al. Pulmonary thrombosis in Covid-19: before, during and after hospital admission. J Thromb Thrombolysis. 2021;51(4):978-84.27.Caruso D, Guido G, Zerunian M, Polidori T, Lucertini E, Pucciarelli F, et al. Postacute Sequelae of COVID-19 Pneumonia: 6-month Chest CT Follow-up. Radiology. 2021:210834.28.Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299(1):E177-E86.29.Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. CT of Post-Acute Lung Complications of COVID-19. Radiology. 2021:211396.30.Wells AU, Devaraj A, Desai SR. Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties. Radiology. 2021;299(1):E216-E8.31.Han X, Fan Y, Alwalid O, Zhang X, Jia X, Zheng Y, et al. Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19. Radiology. 2021:210972.32.Lindahl A, Reijula J, Malmberg LP, Aro M, Vasankari T, Makela MJ. Small airway function in Finnish COVID-19 survivors. Respir Res. 2021;22(1):237.33.Small Airways Disease is a Post-Acute Sequelae of SARS-CoV-2 Infection [Internet]. 2021.34.Lopes AJ, Mafort TT, da Cal MS, Monnerat LB, Litrento PF, Ramos I, et al. Impulse Oscillometry Findings and Their Associations With Lung Ultrasound Signs in COVID-19 Survivors. Respir Care. 2021.35.Wells AU, Devaraj A. Residual Lung Disease at 6-month Follow-up CT after COVID-19: Clinical Significance Is a Key Issue. Radiology. 2021:211284.

REFERÊNCIAS1.Pontone G, Scafuri S, Mancini ME, Agalbato C, Guglielmo M, Baggiano A, et al. Role of computed tomography in COVID-19. J Cardiovasc Comput Tomogr. 2021;15(1):27-36.2.Cereser L, Da Re J, Zuiani C, Girometti R. Chest high-resolution computed tomography is associated to short-time progression to severe disease in patients with COVID-19 pneumonia. Clin Imaging. 2021;70:61-6.3.Hochhegger B, Mandelli NS, Stuker G, Meirelles GSP, Zanon M, Mohammed TL, et al. Coronavirus Disease 2019 (COVID-19) Pneumonia Presentations in Chest Computed Tomography: A Pictorial Review. Curr Probl Diagn Radiol. 2021;50(3):436-42.4.Besutti G, Ottone M, Fasano T, Pattacini P, Iotti V, Spaggiari L, et al. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room. Eur Radiol. 2021.5.Mogami R, Lopes AJ, Araujo Filho RC, de Almeida FCS, Messeder A, Koifman ACB, et al. Chest computed tomography in COVID-19 pneumonia: a retrospective study of 155 patients at a university hospital in Rio de Janeiro, Brazil. Radiol Bras. 2021;54(1):1-8.6.Cau R, Falaschi Z, Pasche A, Danna P, Arioli R, Arru CD, et al. CT findings of COVID-19 pneumonia in ICU-patients. J Public Health Res. 2021.7.Kanne JP, Bai H, Bernheim A, Chung M, Haramati LB, Kallmes DF, et al. COVID-19 Imaging: What We Know Now and What Remains Unknown. Radiology. 2021;299(3):E262-E79.8.Pourhoseingholi MA, Jafari R, Jafari NJ, Rahimi-Bashar F, Nourbakhsh M, Vahedian-Azimi A, et al. Predicting 1-year post-COVID-19 mortality based on chest computed tomography scan. J Med Virol. 2021;93(10):5694-6.9.Kato S, Ishiwata Y, Aoki R, Iwasawa T, Hagiwara E, Ogura T, et al. Imaging of COVID-19: An update of current evidences. Diagn Interv Imaging. 2021;102(9):493-500.10.Ozer H, Kilincer A, Uysal E, Yormaz B, Cebeci H, Durmaz MS, et al. Diagnostic performance of Radiological Society of North America structured reporting language for chest computed tomography findings in patients with COVID-19. Jpn J Radiol. 2021;39(9):877-88.11.Ramanan RV, Joshi AR, Venkataramanan A, Nambi SP, Badhe R. Incidental chest computed tomography findings in asymptomatic Covid-19 patients. A multicentre Indian perspective. Indian J Radiol Imaging. 2021;31(Suppl 1):S45-S52.12.Axiaq A, Almohtadi A, Massias SA, Ngemoh D, Harky A. The role of computed tomography scan in the diagnosis of COVID-19 pneumonia. Curr Opin Pulm Med. 2021;27(3):163-8.13.Ishfaq A, Yousaf Farooq SM, Goraya A, Yousaf M, Gilani SA, Kiran A, et al. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis. Eur J Radiol Open. 2021;8:100350.14.Razek A, Fouda N, Fahmy D, Tanatawy MS, Sultan A, Bilal M, et al. Computed tomography of the chest in patients with COVID-19: what do radiologists want to know? Pol J Radiol. 2021;86:e122-e35.15.Revel MP, Boussouar S, de Margerie-Mellon C, Saab I, Lapotre T, Mompoint D, et al. Study of Thoracic CT in COVID-19: The STOIC Project. Radiology. 2021;301(1):E361-E70.16.Au-Yong I, Higashi Y, Giannotti E, Fogarty A, Morling JR, Grainge M, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiology. 2021:210986.17.Little BP. Disease Severity Scoring for COVID-19: A Welcome (Semi)Quantitative Role for Chest Radiography. Radiology. 2021:212212.18.Prokop M, van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stoger L, Beenen L, et al. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020;296(2):E97-E104.19.Ozel M, Aslan A, Arac S. Use of the COVID-19 Reporting and Data System (CO-RADS) classification and chest computed tomography involvement score (CT-IS) in COVID-19 pneumonia. Radiol Med. 2021;126(5):679-87.20.Byrne D, Neill SBO, Muller NL, Muller CIS, Walsh JP, Jalal S, et al. RSNA Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19: Interobserver Agreement Between Chest Radiologists. Can Assoc Radiol J. 2021;72(1):159-66.21.Fonseca E, Loureiro BMC, Strabelli DG, Farias LPG, Garcia JVR, Gama VAA, et al. Evaluation of the RSNA and CORADS classifications for COVID-19 on chest computed tomography in the Brazilian population. Clinics (Sao Paulo). 2021;76:e2476.22.Barisione E, Grillo F, Ball L, Bianchi R, Grosso M, Morbini P, et al. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems. Virchows Arch. 2021;478(3):471-85.23.Kianzad A, Meijboom LJ, Nossent EJ, Roos E, Schurink B, Bonta PI, et al. COVID-19: Histopathological correlates of imaging patterns on chest computed tomography. Respirology. 2021;26(9):869-77.24.Aesif SW, Bribriesco AC, Yadav R, Nugent SL, Zubkus D, Tan CD, et al. Pulmonary Pathology of COVID-19 Following 8 Weeks to 4 Months of Severe Disease: A Report of Three Cases, Including One With Bilateral Lung Transplantation. Am J Clin Pathol. 2021;155(4):506-14.25.De Cobelli F, Palumbo D, Ciceri F, Landoni G, Ruggeri A, Rovere-Querini P, et al. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021.26.Vlachou M, Drebes A, Candilio L, Weeraman D, Mir N, Murch N, et al. Pulmonary thrombosis in Covid-19: before, during and after hospital admission. J Thromb Thrombolysis. 2021;51(4):978-84.27.Caruso D, Guido G, Zerunian M, Polidori T, Lucertini E, Pucciarelli F, et al. Postacute Sequelae of COVID-19 Pneumonia: 6-month Chest CT Follow-up. Radiology. 2021:210834.28.Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299(1):E177-E86.29.Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. CT of Post-Acute Lung Complications of COVID-19. Radiology. 2021:211396.30.Wells AU, Devaraj A, Desai SR. Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties. Radiology. 2021;299(1):E216-E8.31.Han X, Fan Y, Alwalid O, Zhang X, Jia X, Zheng Y, et al. Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19. Radiology. 2021:210972.32.Lindahl A, Reijula J, Malmberg LP, Aro M, Vasankari T, Makela MJ. Small airway function in Finnish COVID-19 survivors. Respir Res. 2021;22(1):237.33.Small Airways Disease is a Post-Acute Sequelae of SARS-CoV-2 Infection [Internet]. 2021.34.Lopes AJ, Mafort TT, da Cal MS, Monnerat LB, Litrento PF, Ramos I, et al. Impulse Oscillometry Findings and Their Associations With Lung Ultrasound Signs in COVID-19 Survivors. Respir Care. 2021.35.Wells AU, Devaraj A. Residual Lung Disease at 6-month Follow-up CT after COVID-19: Clinical Significance Is a Key Issue. Radiology. 2021:211284.

REFERÊNCIAS1.Pontone G, Scafuri S, Mancini ME, Agalbato C, Guglielmo M, Baggiano A, et al. Role of computed tomography in COVID-19. J Cardiovasc Comput Tomogr. 2021;15(1):27-36.2.Cereser L, Da Re J, Zuiani C, Girometti R. Chest high-resolution computed tomography is associated to short-time progression to severe disease in patients with COVID-19 pneumonia. Clin Imaging. 2021;70:61-6.3.Hochhegger B, Mandelli NS, Stuker G, Meirelles GSP, Zanon M, Mohammed TL, et al. Coronavirus Disease 2019 (COVID-19) Pneumonia Presentations in Chest Computed Tomography: A Pictorial Review. Curr Probl Diagn Radiol. 2021;50(3):436-42.4.Besutti G, Ottone M, Fasano T, Pattacini P, Iotti V, Spaggiari L, et al. The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room. Eur Radiol. 2021.5.Mogami R, Lopes AJ, Araujo Filho RC, de Almeida FCS, Messeder A, Koifman ACB, et al. Chest computed tomography in COVID-19 pneumonia: a retrospective study of 155 patients at a university hospital in Rio de Janeiro, Brazil. Radiol Bras. 2021;54(1):1-8.6.Cau R, Falaschi Z, Pasche A, Danna P, Arioli R, Arru CD, et al. CT findings of COVID-19 pneumonia in ICU-patients. J Public Health Res. 2021.7.Kanne JP, Bai H, Bernheim A, Chung M, Haramati LB, Kallmes DF, et al. COVID-19 Imaging: What We Know Now and What Remains Unknown. Radiology. 2021;299(3):E262-E79.8.Pourhoseingholi MA, Jafari R, Jafari NJ, Rahimi-Bashar F, Nourbakhsh M, Vahedian-Azimi A, et al. Predicting 1-year post-COVID-19 mortality based on chest computed tomography scan. J Med Virol. 2021;93(10):5694-6.9.Kato S, Ishiwata Y, Aoki R, Iwasawa T, Hagiwara E, Ogura T, et al. Imaging of COVID-19: An update of current evidences. Diagn Interv Imaging. 2021;102(9):493-500.10.Ozer H, Kilincer A, Uysal E, Yormaz B, Cebeci H, Durmaz MS, et al. Diagnostic performance of Radiological Society of North America structured reporting language for chest computed tomography findings in patients with COVID-19. Jpn J Radiol. 2021;39(9):877-88.11.Ramanan RV, Joshi AR, Venkataramanan A, Nambi SP, Badhe R. Incidental chest computed tomography findings in asymptomatic Covid-19 patients. A multicentre Indian perspective. Indian J Radiol Imaging. 2021;31(Suppl 1):S45-S52.12.Axiaq A, Almohtadi A, Massias SA, Ngemoh D, Harky A. The role of computed tomography scan in the diagnosis of COVID-19 pneumonia. Curr Opin Pulm Med. 2021;27(3):163-8.13.Ishfaq A, Yousaf Farooq SM, Goraya A, Yousaf M, Gilani SA, Kiran A, et al. Role of High Resolution Computed Tomography chest in the diagnosis and evaluation of COVID -19 patients -A systematic review and meta-analysis. Eur J Radiol Open. 2021;8:100350.14.Razek A, Fouda N, Fahmy D, Tanatawy MS, Sultan A, Bilal M, et al. Computed tomography of the chest in patients with COVID-19: what do radiologists want to know? Pol J Radiol. 2021;86:e122-e35.15.Revel MP, Boussouar S, de Margerie-Mellon C, Saab I, Lapotre T, Mompoint D, et al. Study of Thoracic CT in COVID-19: The STOIC Project. Radiology. 2021;301(1):E361-E70.16.Au-Yong I, Higashi Y, Giannotti E, Fogarty A, Morling JR, Grainge M, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiology. 2021:210986.17.Little BP. Disease Severity Scoring for COVID-19: A Welcome (Semi)Quantitative Role for Chest Radiography. Radiology. 2021:212212.18.Prokop M, van Everdingen W, van Rees Vellinga T, Quarles van Ufford H, Stoger L, Beenen L, et al. CO-RADS: A Categorical CT Assessment Scheme for Patients Suspected of Having COVID-19-Definition and Evaluation. Radiology. 2020;296(2):E97-E104.19.Ozel M, Aslan A, Arac S. Use of the COVID-19 Reporting and Data System (CO-RADS) classification and chest computed tomography involvement score (CT-IS) in COVID-19 pneumonia. Radiol Med. 2021;126(5):679-87.20.Byrne D, Neill SBO, Muller NL, Muller CIS, Walsh JP, Jalal S, et al. RSNA Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19: Interobserver Agreement Between Chest Radiologists. Can Assoc Radiol J. 2021;72(1):159-66.21.Fonseca E, Loureiro BMC, Strabelli DG, Farias LPG, Garcia JVR, Gama VAA, et al. Evaluation of the RSNA and CORADS classifications for COVID-19 on chest computed tomography in the Brazilian population. Clinics (Sao Paulo). 2021;76:e2476.22.Barisione E, Grillo F, Ball L, Bianchi R, Grosso M, Morbini P, et al. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems. Virchows Arch. 2021;478(3):471-85.23.Kianzad A, Meijboom LJ, Nossent EJ, Roos E, Schurink B, Bonta PI, et al. COVID-19: Histopathological correlates of imaging patterns on chest computed tomography. Respirology. 2021;26(9):869-77.24.Aesif SW, Bribriesco AC, Yadav R, Nugent SL, Zubkus D, Tan CD, et al. Pulmonary Pathology of COVID-19 Following 8 Weeks to 4 Months of Severe Disease: A Report of Three Cases, Including One With Bilateral Lung Transplantation. Am J Clin Pathol. 2021;155(4):506-14.25.De Cobelli F, Palumbo D, Ciceri F, Landoni G, Ruggeri A, Rovere-Querini P, et al. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021.26.Vlachou M, Drebes A, Candilio L, Weeraman D, Mir N, Murch N, et al. Pulmonary thrombosis in Covid-19: before, during and after hospital admission. J Thromb Thrombolysis. 2021;51(4):978-84.27.Caruso D, Guido G, Zerunian M, Polidori T, Lucertini E, Pucciarelli F, et al. Postacute Sequelae of COVID-19 Pneumonia: 6-month Chest CT Follow-up. Radiology. 2021:210834.28.Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299(1):E177-E86.29.Solomon JJ, Heyman B, Ko JP, Condos R, Lynch DA. CT of Post-Acute Lung Complications of COVID-19. Radiology. 2021:211396.30.Wells AU, Devaraj A, Desai SR. Interstitial Lung Disease after COVID-19 Infection: A Catalog of Uncertainties. Radiology. 2021;299(1):E216-E8.31.Han X, Fan Y, Alwalid O, Zhang X, Jia X, Zheng Y, et al. Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19. Radiology. 2021:210972.32.Lindahl A, Reijula J, Malmberg LP, Aro M, Vasankari T, Makela MJ. Small airway function in Finnish COVID-19 survivors. Respir Res. 2021;22(1):237.33.Small Airways Disease is a Post-Acute Sequelae of SARS-CoV-2 Infection [Internet]. 2021.34.Lopes AJ, Mafort TT, da Cal MS, Monnerat LB, Litrento PF, Ramos I, et al. Impulse Oscillometry Findings and Their Associations With Lung Ultrasound Signs in COVID-19 Survivors. Respir Care. 2021.35.Wells AU, Devaraj A. Residual Lung Disease at 6-month Follow-up CT after COVID-19: Clinical Significance Is a Key Issue. Radiology. 2021:211284.

Alexa brings us the story of the Radium Girls.https://en.wikipedia.org/wiki/Radium_Girlshttps://www.dailykos.com/stories/2009/3/15/708873/- https://environmentalhistory.org/people/radiumgirls/ Radiological Society https://pubs.rsna.org/doi/10.1148/radiol.14141352 http://www.nukes.org/MAp/radiumgirls.html https://www.nprillinois.org/post/radium-girls-illinois-tragedy#stream/ 0 https://nclnet.org/about-ncl/about-us/history/

This week we take a deep-dive into another potential hypergrowth stock-pick, Nano-X. This was a fun episode to record, and we both changed our minds twice about whether it was a smart buy or just tantamount to setting our money on fire, during the episode research! Nano-X Imaging promises to make medical imaging more accessible and more affordable for everyone. They have developed a new type of X-ray technology that is smaller, lighter and less expensive to manufacture and operate, and an innovative pay-per-scan business model. However, with no earnings, no sales and as yet, no regulatory approval, is this revolutionary technology too good to be true? Two-thirds of the world's population does not have easy access to medical imaging. With its new energy-efficient X-ray technology and innovative pay-per-scan business model, Nano-X is hoping to make this potentially life-saving service available to urgent care centres, outpatient clinics and rural areas all over the globe Using a semiconductor-based digital X-ray source, Nano-X has developed an X-ray tube that is less expensive to manufacture, smaller, lighter, and able to work at room temperatures, removing the need for large and expensive cooling components. The Nanox.ARC is a medical imaging device using their new X-ray technology and is estimated to cost $10K-15K, compared to $1M-3M for traditional X-ray machines They are innovating with an MSaaS (medical screening as a service) business model, where machines are provided for free or at low cost, and revenue is received per scan. Scans are estimated to cost $40 each on average (compared to $300 for a traditional X-ray), of which Nano-X receives $14 and the remainder is kept by the service provider. Contracts with minimum scan volumes result in a reliable recurring revenue stream Nano-X has contracts to deliver 5,150 Nanox.ARC systems with 9 service providers in 13 countries, and agreements (no obligation) with USARAD and SK Telecom to deliver a further 3,000 and 2,500 units respectively. They aim to deliver 1,000 units in the first quarter of 2022, and a total of 15,000 units by 2024, which would result in a minimum annual revenue of $400M The Nanox.ARC machines will be connected to the Nanox.CLOUD, an online service that allows scans to be shared with specialists across the world in near realtime. This is standard practice in many developed countries, but this may be extremely beneficial for regions that do not have this capability and do not have local radiologists A 510(k) application for a single-source imaging device was submitted to the FDA in January of 2020 and a decision is expected soon. A 501(k) clearance allows a device to be marketed as safe and effective and is equivalent to an existing legally marketed device. Even with FDA clearance, there are many challenges to overcome to bring the product to market Nano-X demonstrated the technology in a live stream at the Radiological Society of North America (RSNA) meeting in Nov 2020. However, there remains debate over whether or not the technology is real. Will Nano-X disrupt the global medical imaging industry or go down in flames as the next Theranos? ----- If you enjoyed this episode, please consider subscribing to the Telescope Investing website at https://telescopeinvesting.com/subscribe/ Or you can contact the hosts Luke & Albert at https://twitter.com/LukeTelescope https://twitter.com/AlbertTelescope

February 18, 2021 Join us for an inspirational conversation with James P. Borgstede, MD, FACR, professor and vice chairman of radiology at the University of Colorado, as he shares his remarkable journey from paper boy in Edwardsville, IL (which financed the purchase of an engagement ring!) to his impressive distinction as being the only person to have served as past president of the Radiological Society of North America (RSNA), the International Society of Radiology (ISR), the American College of Radiology (ACR), the American Board of Radiology (ABR), the Colorado Physician Health Program and the Colorado State Board of Medical Examiners.

August 20, 2020In this episode, Katherine P. Andriole, Ph.D., FSIIM, Associate Professor of Radiology at Harvard Medical School, Brigham and Women’s Hospital and the Director of Research Strategy and Operations at the MGH & BWH Center for Clinical Data Science (CCDS), discusses her early years in Connecticut as a competitive swimmer and distance runner and her journey to receiving the inaugural RADxx Trailblazer Award recognizing her as a pioneering woman leader in Imaging Informatics. Along the way she was elected to the Branford Sports Hall of Fame and earned degrees from Duke, Oxford and Yale Universities. She was instrumental in designing, building and implementing picture archiving and communication systems (PACS) before they became commercial entities, has served in multiple leadership roles for the Society of Imaging Informatics in Medicine (SIIM), the Radiological Society of North America (RSNA) and the American College of Radiology (ACR). Join us for this inspiring conversation with a true trailblazer who credits her mother as being as being her most wonderful mentor of all.

This is a special episode recorded during the Covid-19 pandemic focusing on the diagnosis and imaging features of Covid-19 infection. Our guest is Dr. Maria Barile, our local expert in the Division of Cardiothoracic Imaging. We discuss the following topics: 1. Epidemiology of COVID-19 infection 2. Utility and role of PCR, XR, and CT in screening and diagnosis 3. Imaging appearances of COVID-19 (typical, indeterminate, atypical) and progression of disease as well as recommended radiology reporting practices 4. Fleischner Society recommendations for imaging PUI or COVID-19 positive patients Guest: Maria Barile, MD. Assistant Professor of Radiology, Division of Cardiothoracic Radiology, UMMS Dept of Radiology. Hosts: Hao Lo, MD, MBA. Associate Professor of Radiology, Division of Emergency Radiology, UMMS Dept of Radiology. Christopher Cerniglia, DO, ME, FAOCR. Associate Professor of Radiology, Division of Musculoskeletal Imaging & Intervention, UMMS Dept of Radiology Resources: 1. Jeffrey P. Kanne , Brent P. Little, Jonathan H. Chung, Brett M. Elicker, Loren H. Ketai. Essentials for Radiologists on COVID-19: An Update—Radiology Scientific Expert Panel. Radiology. 2020. Feb 27. https://doi.org/10.1148/radiol.2020200527 2. Scott Simpson et al. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiology: Cardiothoracic Imaging. 2020. Vol. 2, No. 2. https://doi.org/10.1148/ryct.2020200152 3. Fengxiang Song*, Nannan Shi*, Fei Shan, Zhiyong Zhang, Jie Shen, Hongzhou Lu, Yun Ling, Yebin Jiang. Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. Vol. 295, No.1. https://doi.org/10.1148/radiol.2020200274 4. Geoffrey D Rubin et al. The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society. Radiology. 2020. Published Online:Apr 7 2020https://doi.org/10.1148/radiol.2020201365 5. RSNA Covid-19 resources: https://www.rsna.org/covid-19

The meetings industry is being hit hard and fast by event cancellations in the wake of the Coronavirus. For many there is a panic on what to do if their participants cannot come or the whole convention is cancelled.  How to un a virutal meeting is being talked about all across the world.  But hosting a virtual event is not simply livestreaming speakers or holding a webinar.  You have to do it right if you want to engage your audience.   As a keynote speaker and professional master of ceremonies / emCee, Thom Singer is trying to monitor all that is occurring in the meetings industry.  Thom knows a little about virtual events (he and Eliz Green have hosted several events with their "Conference Talk Show" product)... but Thom knows that if you want to really be informed you have to talk to the experts.  Thom always says "Success Leaves Clues" so he turned to the leader in the world of virtual conferences, Jim Parker.  Jim has been working with live events for 35 years, and began live streaming conferences 11 years ago.     In episode 542 of "Cool Things Entrepreneurs Do" thom asks Jim for details on how to run a virtual meeting?  WOW, if you have never run a digital version of a conference, you have to hear what Jim has to say on this podcast. They talk mistake, technology, attendee engagement, bringing virtual attendees to the live event next year, and many other best practices.   Find out more about Digitell Inc at https://digitellinc.com/   About Jim Parker   Jim Parker is President and CEO of Digitell, Inc., a full service multimedia company that specializes in Live Streaming, High End Webcasts and Content Capture/Distribution Systems.  Mr. Parker is a 35 year veteran in the conference industry, servicing 90 organizations, such as the Radiological Society of North America (RSNA), and the American Institute of Certified Public Accountants (AICPA). With a staff of over 50, Digitell provides their clients with everything from consulting and event management, to registration and web page creation, live streaming, webcasts, content capture, tech support and event reporting. A civil engineer by trade, Jim’s analytical approach to the logistics necessary to execute the services Digitell offers, has provided them with a reputation of offering “best practice” products, services and customer support.   About Digitell   Digitell, Inc. is a Digital Multimedia Development company specializing in assisting organizations on how to leverage their educational content online. With over 35 years’ experience servicing 150 organizations, Digitell utilizes this wealth of experience and knowledge to assist their clients in developing customized and cutting edge solutions to capturing, delivering and managing their online education. From their newly released education APP, to OPUS DX, a feature rich, fully managed Digital Experience Platform, their services are designed to engage users with a superior digital experience while accessing  live streams, webinars and on-demand education. Digitell can meet the needs of any organization looking to bring their conference or education online.  To learn more visit digitellinc.com.   About Thom Singer   Thom Singer is a keynote speaker, emcee, and digital event host (see http://www.ConferenceTalkShow.com).  He is the host of two podcasts and the author of 12 books.     https://thomsinger.com/podcast/how-to-run-a-virtual-meeting 

November 21, 2019In this episode, Valerie P. Jackson, MD, executive director of the American Board of Radiology (ABR) and president of the Radiological Society of North America (RSNA) discusses her how her passion for breast imaging led to her serving in numerous leadership positions with national organizations including the ACR, SBI, SCARD and her current roles at the ABR and RSNA. She shares how a series of great mentors provided opportunities and reinforcement which helped her overcome her reluctance to lead and fueled her passion for education, research and volunteerism. You will hear how the lessons she learned from her job as a house keeper in a hospital, raising her son, and her love of photography has shaped her approach to leadership.

On today’s podcast we feature the audio from a webcast aired live on August 22, 2018 titled “ATG Health Sciences Special Issue Panel Discussion”. Leah Hinds, Executive Director of the Charleston Conference is joined by three of our featured article authors for a discussion of the upcoming September issue of Against the Grain. “The (Not So) Accidental Ontologist and other Tales of Alternative Librarianship” by David Bender, Librarian from Radiological Society of North America “Hitting our Stride: Reflections Four Years Later from a Born-Digital Medical Library” by Elizabeth Lorbeer, Western Michigan University Homer Stryker M.D. School of Medicine “One Health: Connecting the Dots”  by Pamela Rose, Health Sciences Library, University at Buffalo Links: David Bender’s Slides Liz Lorbeer’s Slides Pamela Rose’s Slides Poll Results Attendee Chat Log  

Host: Matt Birnholz, MD Tune in for significant summaries from the Radiological Society of North America's 96th Scientific Assembly and Annual Meeting, November 28th through December 3rd in Chicago.

Host: Jason Birnholz, MD Host Dr. Jason Birnholz talks with experts on the conference floor from the Radiological Society of North America's 96th Scientific Assembly and Annual Meeting in Chicago. His guests include: Dr. Candice Aitken, radiation oncologist and assistant professor of medicine at Dartmouth Medical School Dr. Jacques Souquet, founder and CEO of SuperSonic Imagine Dr. Judy Kalinyak, chief medical officer of Naviscan Dr. William Denman, chief medical officer of GE Healthcare

Tune in to hear important highlights from research findings presented at the Radiological Society of North America's 2009 Scientific Assembly and Annual Meeting, November 29th through December 4th.

Host: Jason Birnholz, MD Host Dr. Jason Birnholz reports from the Radiological Society of North America's 95th Scientific Assembly and Annual Meeting, which took place November 29th through December 6th in Chicago. In this segment, he speaks with Dr. Wendie Berg, from Johns Hopkins University, about early detection and breast cancer, and Dr. Alexis Kelekis, assistant professor of radiology at the University of Athens, about percutaneous disc decompression treatment for herniated disc.

Host: Jason Birnholz, MD This program features Dr. David Cosgrove, professor of clinical ultrasound, Imperial College School of Medicine, and honorary consultant in radiology at the Hammersmith Hospital in London. He is an expert in ultrasound, known around the world, and is the author of numerous publications. He speaks with host Dr. Jason Birnholz about a new form of ultrasound imaging— elastography, or sheer wave imaging — for detecting breast cancer. Next, Dr. Birhnolz sits down with Dr. Michelle Brown, associate professor of radiology at the University of California, San Diego. She is presenting research on detection of placenta accreta using MRI. The incidence of placenta accreta has increased ten-fold since 1950, as the incidence of the primary risk factor, cesarian section, has also increased. These interviews were recorded at the Radiological Society of North America's 95th Scientific Assembly and Annual Meeting, which took place November 29th through December 4th in Chicago.

Host: Jason Birnholz, MD These interviews were recorded at the Radiological Society of North America's 95th Scientific Assembly and Annual Meeting, which took place November 29th through December 4th in Chicago. Host Dr. Jason Birnholz talks with Dr. Rozemarijn Vliegenthart, from the University Medical Center Groningen in the Netherlands, who presented at the conference a paper entitled, "High Prevalence of Treatable Severe Coronary Artery Disease: Findings in a Randomized Controlled Trial in Cardiac Asymptomatic Peripheral Arterial Disease Patients." Dr. Birnholz also sits down with Dr. Asim F. Choudhri, from Johns Hopkins University in Baltimore, to talk about tele-radiology and smartphones.

Guest: Stamatia Destounis, MD Host: Jason Birnholz, MD These interviews were recorded at the Radiological Society of North America's 95th Scientific Assembly and Annual Meeting, which took place November 29th through December 4th, 2009, in Chicago. Host Dr. Jason Birnholz talks with Dr. Stamatia Destounis, associate clinical professor of radiology at the University of Rochester, and a practicing radiologist at the Elizabeth Wende Breast Care Center in Rochester, New York. Dr. Destounis presented a paper entitled "The Role of Ultrasound Elastography for Differentiating Benign from Malignant Breast Lesions: Can Benign Result Biopsies Be Reduced?"

Guest: Rizwan Aslam, MD Host: Jason Birnholz, MD Guest: Michael J. Welch, PhD Host Dr. Jason Birnholz takes you to the 2008 Radiological Society of North America (RSNA) 94th Scientific Assembly and Annual Meeting, held in Chicago November 30 through December 5. Dr. Birnholz talks with three of the meeting's key presenters. He sits down first with Dr. Michael Welch, co-director of the division of radiological sciences at Washington University's Mallinckrodt Institute of Radiology in St. Louis, Missouri, who highlights advances in nanotechnology for imaging and drug delivery. Next, Dr. David Weinreb, radiology resident at the Hospital of Saint Raphael in New Haven, Connecticut, discusses the advantages of portable CT for treating acute stroke patients in the emergency department. Finally, Dr. Rizwan Aslam, assistant clinical professor of radiology at the University of California San Francisco School of Medicine, reports on mineral density assessment with CT colonography, concurrent to colorectal cancer screening.